Professor of Medicine
Cardiology
Dr. Gregory M. Lanza, MD
|
|
Give Review
Gregory Lanza works in the field of Cardiology. He went to Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He received awards:"Searle Career Development Award", "Missouri Affiliate Beginning Grant", "Research Foundation Award", "Fellowship", "Scholarship Award", "Fellowship Award", "Fellowship, Missouri Affiliate", "Phi Kappa Phi Honor Society", "Gamma Sigma Delta Agricultural Honor Society", "Scholarship", "Graduate Student Award", "Medical student research grant" and "Fellow (FACC)". Gregory M. Lanza, MD is a published physician as well. He has 99 publications published. The latest was: Dual-therapy with v3-targeted Sn2 lipase-labile Fumagillin-prodrug Nanoparticles and Zoledronic Acid in the Vx2 Rabbit Tumor Model. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Dual-therapy with αvβ3-targeted Sn2 lipase-labile Fumagillin-prodrug Nanoparticles and Zoledronic Acid in the Vx2 Rabbit Tumor Model.
- Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.
- Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits.
- A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.
- Improved quantitative (19) F MR molecular imaging with flip angle calibration and B1 -mapping compensation.
- Physicochemical signatures of nanoparticle-dependent complement activation.
- Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces.
- Balanced UTE-SSFP for F MR imaging of complex spectra.
- Angiogenesis and airway reactivity in asthmatic Brown Norway rats.
- Fumagillin Prodrug Nanotherapy Suppresses Macrophage Inflammatory Response via Endothelial Nitric Oxide.
- MR Cholangiography Demonstrates Unsuspected Rapid Biliary Clearance of Nanoparticles in Rodents: Implications for Clinical Translation.
- Antagonizing the αv β3 Integrin Inhibits Angiogenesis and Impairs Woven but Not Lamellar Bone Formation Induced by Mechanical Loading.
- Fourth annual conference of the american society for nanomedicine.
- Rapamycin nanoparticles target Defective autophagy in muscular dystrophy to enhance both strength and cardiac function.
- Multicolor computed tomographic molecular imaging with noncrystalline high-metal-density nanobeacons.
- Molecular imaging with computed tomography.
- Assessing the barriers to image-guided drug delivery.
- Perfluorocarbon Nanoparticles for Physiological and Molecular Imaging and Therapy.
- Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.
- A brief account of nanoparticle contrast agents for photoacoustic imaging.
- Molecular MR Imaging of Neovascular Progression in the Vx2 Tumor with αvβ3-Targeted Paramagnetic Nanoparticles.
- Assessing intrarenal nonperfusion and vascular leakage in Acute kidney injury with multinuclear (1) H/(19) F MRI and perfluorocarbon nanoparticles.
- Characterization of early neovascular response to Acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging.
- Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence.
- Melittin derived peptides for nanoparticle based siRNA transfection.
- Programmable nanoparticle functionalization for in vivo targeting.
- Angiogenesis is required for stress fracture healing in rats.
- Photoacoustic Sentinel Lymph Node Imaging with Self-Assembled Copper Neodecanoate Nanoparticles.
- Manganese-based MRI contrast agents: past, present and future.
- Interaction of Melittin Peptides with Perfluorocarbon Nanoemulsion Particles.
- Use of smoothing splines for analysis of backscattered ultrasonic waveforms: application to monitoring of steroid treatment of dystrophic mice.
- Recent advances in colloidal gold nanobeacons for molecular photoacoustic imaging.
- Emerging contrast agents for photoacoustic imaging.
- Diffusional mechanisms augment the fluorine MR relaxation in paramagnetic perfluorocarbon nanoparticles that provides a "relaxation switch" for detecting cellular endo...
- Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles.
- Nanotechnology in interventional cardiology.
- A generalized strategy for designing (19) F/(1) H dual-frequency MRI coil for small animal imaging at 4.7 Tesla.
- Synthesis of NanoQ, a Copper-Based Contrast Agent for High-Resolution Magnetic Resonance Imaging Characterization of Human Thrombus.
- Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
- A fibrin-specific thrombolytic nanomedicine approach to Acute ischemic stroke.
- Simultaneous dual-nuclei imaging for motion corrected detection and quantification of (19) F imaging agents.
- Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.
- Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles.
- Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.
- Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3T.
- A facile synthesis of novel self-assembled gold nanorods designed for near-infrared imaging.
- MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model.
- Rationale for a nanomedicine approach to thrombolytic therapy.
- Revisiting an old friend: manganese-based MRI contrast agents.
- Molecular imaging of angiogenic therapy in peripheral vascular Disease with alphanubeta3-integrin-targeted nanoparticles.
- Application of a real-time, calculable limiting form of the Renyi entropy for molecular imaging of tumors.
- MR molecular imaging of Aortic angiogenesis.
- Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.
- Quantitative magnetic resonance fluorine imaging: today and tomorrow.
- Imaging atherosclerosis and vulnerable plaque.
- Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model.
- Conquering the dark side: colloidal iron oxide nanoparticles.
- Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle.
- Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.
- Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
- Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
- High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.
- Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.
- In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles.
- Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
- Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy.
- Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.
- Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
- Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
- Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets.
- Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.
- Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides.
- Sensitive ultrasonic delineation of steroid treatment in living dystrophic mice with energy-based and entropy-based radio frequency signal processing.
- 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons.
- Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles.
- Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
- Molecular imaging by cardiovascular MR.
- Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents.
- Spectral properties of a bifunctional PARACEST europium chelate: an intermediate for targeted imaging applications.
- Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.
- Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
- Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo.
- Acoustic activation of targeted liquid perfluorocarbon nanoparticles does not compromise endothelial integrity.
- In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla.
- Molecular imaging by MRI.
- Targeted magnetic resonance imaging contrast agents.
- MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.
- Characterization of digital waveforms using thermodynamic analogs: applications to detection of materials Defects.
- Molecular imaging of human thrombus with computed tomography.
- Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
- Acoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imaging.
- 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.
- Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.
- Magnetic resonance molecular imaging with nanoparticles.
- Quantification of stenotic mitral Valve area with magnetic resonance imaging and comparison with Doppler ultrasound.
- Ultrasonic delineation of Aortic microstructure: the relative contribution of elastin and collagen to Aortic elasticity.
- Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI.
Schools
Northwestern Center Feinberg School of Medicine
Barnes Jewish Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioversion, Elective
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Great West Healthcare-Cigna PPO
- LocalPlus
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Homestate Health Plan
- Choice Care PPO
- Medicaid
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Searle Career Development Award
- Missouri Affiliate – Beginning Grant
- Research Foundation Award
- Fellowship
- Scholarship Award
- Fellowship Award
- Fellowship, Missouri Affiliate
- Phi Kappa Phi Honor Society
- Gamma Sigma Delta Agricultural Honor Society
- Scholarship
- Graduate Student Award
- Medical student research grant
- Fellow (FACC)
Education
-
Washington University -
Washington University - Barnes-Jewish Hospital -
Northwestern University Feinberg School of Medicine
Hospital
-
Barnes-Jewish Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457378994 |
| Last Name Of The Provider | LANZA |
| First Name Of The Provider | GREGORY |
| View All |
Similar Doctors
|
|
Dr. Weining D. Xu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip A. Ludbrook, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gil M. Vardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farhaan A. Ahmad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandor J. Kovacs Jr., MD |
|
Dr. Arthur J. Labovitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad Tahir, MD |
|
Dr. Clark R. McKenzie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bernard R. Chaitman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nizar A. Assi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rama K. Gondi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Kenzora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wajeehuddin Mohammed, MD |
|
|
Dr. Heather H. Cha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zia M. Ahmad, MD
This Doctor is OpenDoctor Recommended.
|